Anthony P Adamis's Net Worth
$4.46 Million
Who is Anthony P Adamis?
Anthony P Adamis has an estimated net worth of $4.46 Million. This is based on reported shares across multiple companies, which include EYETECH PHARMACEUTICALS INC, and EyePoint Pharmaceuticals, Inc..
SEC CIK
Anthony P Adamis's CIK is 0001277479
Past Insider Trading and Trends
2005 was Anthony P Adamis's most active year for acquiring shares with 7 total transactions. Anthony P Adamis's most active month to acquire stocks was the month of May. 2005 was Anthony P Adamis's most active year for disposing of shares, totalling 13 transactions. Anthony P Adamis's most active month to dispose stocks was the month of December. 2004 saw Anthony P Adamis paying a total of $598,200.00 for 185,000 shares, this is the most they've acquired in one year. In 2005 Anthony P Adamis cashed out on 582,419 shares for a total of $3,076,456.86, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
EYETECH PHARMACEUTICALS INC No price found
Chief Scientific OfficerAnthony P Adamis used to own units in Common Stock but no longer holds any shares there.acquired a total of 337,500 shares in EYETECH PHARMACEUTICALS INC at a cost of $307,125.00, Anthony also disposed a total of 400,535 shares of EYETECH PHARMACEUTICALS INC equalling to $4,736,422.86.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -225.01K |
—
|
—
|
0
|
Nov 14
| |||
Form 4
| +93.20% | 102.48K |
$9.52 | -$1,592,078.56 | 212.45K |
Nov 3
| |||
Form 4
| -4.62% | -5.33K |
$11.35 | -$60,438.75 | 109.97K |
Scheduled
|
Aug 1
| ||
Form 4
| -4.41% | -5.33K |
$12.59 | -$67,041.75 | 115.29K |
Scheduled
|
Jul 1
| ||
Form 4
| +329.01% | 92.5K |
$0.01 | $925.00 | 120.61K |
Jun 28
| |||
Form 4
| -15.92% | -5.33K |
$12.95 | -$68,958.75 | 28.11K |
Scheduled
|
Jun 1
| ||
Form 4
| +69.97% | 13.52K |
$21.32 | -$275,999.77 | 32.84K |
Jan 5
| |||
Form 4
|
—
|
0
|
$22.85 | -$705,739.28 | 19.32K |
Scheduled
|
Jan 3 - Jan 4
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
| -69.05% | -43.12K |
$38.50 | -$1,659,966.00 | 19.32K |
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EyePoint Pharmaceuticals, Inc. (EYPT) Snapshot price: $7.97
InvestorAnthony P Adamis owns 4,000 units of Common Stock which is worth $31,880.00. In the year 2023 Anthony P Adamis acquired a total of 4,000 shares in EyePoint Pharmaceuticals, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +100.00% | 2K |
—
|
—
| 4K |
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
∞
| 2K |
—
|
—
| 2K |
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||